Seeing Is Believing
Currently out of the existing stock ratings of Matt Miksic, 198 are a BUY (81.82%), 32 are a HOLD (13.22%), 12 are a SELL (4.96%).
Analyst Matt Miksic works at BARCLAYS with a stock forecast success ratio of 54.3% fulfilled within 244.14 days on average.
Matt Miksic’s has documented 514 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LIVN, LivaNova PLC at 26-Feb-2024.
Analyst best performing recommendations are on ISRG (INTUITIVE SURGICAL).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 10/17/2022. The price target of $235 was fulfilled within 8 days with a profit of $44.88 (23.61%) receiving and performance score of 29.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
125
$14.48 (13.10%)
114
14 days ago
4/5 (80%)
$14.89 (13.52%)
388
Buy
141
$30.48 (27.58%)
133
2 months 23 days ago
13/21 (61.9%)
$28.99 (25.88%)
291
Buy
126
$15.48 (14.01%)
130
2 months 24 days ago
7/14 (50%)
$13.55 (12.05%)
292
Buy
127
$16.48 (14.91%)
110
2 months 24 days ago
12/18 (66.67%)
$14.55 (12.94%)
190
Buy
125
$14.48 (13.10%)
125
2 months 25 days ago
6/7 (85.71%)
$14.23 (12.85%)
250
Which stock is Matt Miksic is most bullish on?
Which stock is Matt Miksic is most reserved on?
What Year was the first public recommendation made by Matt Miksic?